GITRL:GITR[Biotinylated] Inhibitor Screening Assay Kit

Catalog #
72061
$1,070 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The GITR:GITRL [Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of GITR:GITRL signaling. This kit comes in a convenient 96 well format, with biotin-labeled GITR (CD357), purified GITRL, streptavidin-labeled HRP, and Immunobuffer for 100 binding reactions. The key to this kit is the high sensitivity of detection of biotin-labeled GITR by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, GITRL is coated on a 96-well plate. Next, GITR is incubated with GITRL on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

Need us to run inhibitor screens or profile your compounds against GITRL:GITR[Biotinylated]? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
Glucocorticoid-induced TNFR-Related Protein, Tumor Necrosis Factor Receptor Superfamily member 18, TNFRSF18, Activation-Inducible TNFR Family Receptor, AITR, and CD357, activity assay kit
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Species
Human
Format
Catalog
Number

Component

Amount

Storage
71256 GITR, Biotin-labeled 2 µg -80°C


Avoid freeze/
thaw cycles!
71190 GITRL-His 10 µg -80°C
79742 Streptavidin-HRP 15 µl +4°C
79311 3x Immunobuffer 1 50 ml -20°C
79728 Blocking Buffer 2 50 ml +4°C
79670 ELISA ECL substrate A
(transparent bottle)
6 ml RT
ELISA ECL substrate B
(brown bottle)
6 ml RT
79699 White 96-well microplate 1 +4°C
UniProt #
GITRL: Q9UNG2; GITR: Q9Y5U5
Background
Glucocorticoid-induced TNFR-related protein (GITR) is a member of the TNFR superfamily, expressed in a number of cells including T cells, natural killer (NK) cells and antigen-presenting cells (APC). GITRL, GITR’s natural ligand, is expressed mainly by APCs and GITR:GITRL interaction is important for activation of the immune system. Agonistic antibodies targeting GITR are actively being pursued as potential immuno oncology therapies.